Centogene: Difference between revisions
Created company page — Germany |
Added founded year: 2006 |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Company | {{Company | ||
|name=Centogene | |name=Centogene | ||
|founded=2006 | |||
|location=Rostock, Germany | |location=Rostock, Germany | ||
|category=Rare Disease / Genomics | |category=Rare Disease / Genomics | ||
| Line 11: | Line 12: | ||
== Funding == | == Funding == | ||
'''Valuation:''' Sold operating assets for €8.7M (2025); was Nasdaq-listed | |||
Publicly listed (Nasdaq: CNTG) | Publicly listed (Nasdaq: CNTG) | ||